PSDV Stock News 3.40 05/13/2014 16:50:27 Psivida Corp (PSDV)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Psivida Corp (PSDV) 3.40 $PSDV

pSivida Corp. Reports Third Quarter 2014 Results
Business Wire - 1 hr 49 mins ago
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its third quarter ended March 31, 2014.

pSivida Presents Preclinical Data Demonstrating Sustained Release of Avastin Using Tethadur at ARVO Annual Meeting
Business Wire - Mon May 05, 2:00PM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release products for treating eye diseases, today announced that the Company presented the first peer-reviewed preclinical data demonstrating the use of pSivida's Tethadur(TM) technology to provide sustained release of Avastin at the 14th Annual Meeting of ARVO (Association for Research in Vision and Ophthalmology).

pSivida Corp Announces Third Quarter 2014 Financial Results Release Date and Conference Call Information
Business Wire - Fri May 02, 7:01AM CDT
pSivida Corp. (NASDAQ SDV) (ASX VA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its financial results for the third quarter of fiscal year 2014 will be released after the market close on Tuesday, May 13, 2014, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.

pSivida to commercialise ILUVIEN for DME in Australia/New Zealand through STA
M2 - Tue Apr 29, 5:13AM CDT
Drug delivery company pSivida (NasdaqGM SDV) (ASX VA.AX) disclosed on Monday the launch of an exclusive agreement for the distribution of ILUVIEN for the treatment of diabetic macular edema (DME) in Australia and New Zealand.

pSivida Reports Australia/New Zealand Distribution Agreement for ILUVIEN(R) for DME
Business Wire - Mon Apr 28, 6:06AM CDT
pSivida Corp. (NASDAQ SDV) (ASX VA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee Alimera Sciences has signed an exclusive agreement with Specialised Therapeutics Australia (STA) for the distribution in Australia and New Zealand of ILUVIEN(R) for the treatment of diabetic macular edema (DME). Under the agreement, STA also will handle all regulatory and commercial activities for ILUVIEN in those countries.

pSivida Selected to Present at 2014 Opthalmology Innovation Summit
Business Wire - Wed Apr 23, 7:45AM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release products for treating eye diseases, today announced that pSivida has been selected for the Ophthalmic Companies Showcase at The Ophthalmology Innovation Summit (OIS), April 24, 2014 at the Seaport Hotel in Boston, MA. pSivida's president and chief executive officer, Dr. Paul Ashton, will discuss sustained delivery of antibodies and other large biologics with pSivida's Tethadur(TM) technology.

Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 3:45PM CDT
The FDA accepted Alimera Sciences' re-submitted NDA for Iluvien. PDUFA date for Iluvien is now set for Sep 26, 2014.

pSivida announces 26 September 2014 as the PDUFA date for ILUVIEN
M2 - Tue Apr 15, 5:51AM CDT
Drug delivery company pSivida (NasdaqGM SDV) (ASX VA.AX) declared on Monday that the US Food and Drug Administration (FDA) has set Prescription Drug User Fee Act (PDUFA) goal date of 26 September 2014 for ILUVIEN.

pSivida Announces September 26, 2014 PDUFA Date for ILUVIEN(R)
Business Wire - Mon Apr 14, 6:04AM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) goal date of September 26, 2014 for ILUVIEN(R) following the recent resubmission of the New Drug Application (NDA) by pSivida's licensee, Alimera Sciences. The FDA acknowledged the resubmission as received as a complete class 2 response to the FDA's October 2013 complete response letter.

pSivida CEO to Discuss Company's Sustained Release Delivery System for Biologics at Two Upcoming Conferences
Business Wire - Tue Apr 01, 9:09AM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release products for treating eye diseases, today announced that pSivida's president and chief executive officer, Dr. Paul Ashton, will discuss pSivida's Tethadur(TM) technology designed to provide sustained delivery of biologics at The World Ophthalmology Conference in Tokyo, April 2-6 and at the SMi Inaugural Conference on Biosimilars and Biobetters USA, in Iselin, New Jersey, April 7-8.

pSivida Announces Resubmission of New Drug Application for ILUVIEN(R)
Business Wire - Thu Mar 27, 6:05AM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA). In the resubmission, pSivida's licensee, Alimera Sciences, responded to questions raised in the FDA's October 2013 complete response letter and provided a safety update, which included commercial experience with ILUVIEN in Europe.

pSivida Corp. Announces $7.0 Million Investment by RA Capital
Business Wire - Thu Mar 13, 8:46AM CDT
pSivida Corp. (NASDAQ SDV) (ASX VA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that RA Capital has entered into a securities purchase agreement with the Company to invest approximately $7.0 million in a registered direct offering through the sale of a total of 1.7 million shares of the Company's common stock at a per share price of $4.11.

10-Q: PSIVIDA CORP.
Edgar Online - Wed Feb 12, 9:31AM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

pSivida Announces ILUVIEN(R) for DME Accepted by National Health Service Scotland
Business Wire - Mon Feb 10, 8:05AM CST
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Scottish Medicines Consortium (SMC) has accepted ILUVIEN(R) for use within the National Health Service (NHS) Scotland under a simple patient access scheme. ILUVIEN will be available in the NHS Scotland to treat vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies in pseudophakic eyes (those that have undergone cataract surgery).

pSivida Corp. Reports Second Quarter 2014 Results
Business Wire - Fri Feb 07, 3:00PM CST
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its second quarter ended December 31, 2013.

pSivida CEO to Present at 16th Annual BioCEO & Investor Conference February 11
Business Wire - Thu Feb 06, 9:24AM CST
pSivida Corp. (NASDAQ SDV)(ASX VA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that Dr. Paul Ashton, President and CEO, will present at the 16th Annual BioCEO & Investor Conference, being held at the Waldorf-Astoria Hotel in New York, Monday and Tuesday, February 10 and 11. Dr. Ashton will make his presentation on Tuesday, February 11 at 9:30 EST. A webcast of the presentation will be available at: http://www.veracast.com/webcasts/bio/ceoinves...464352.cfm or at the company's website: www.psivida.com. There will be a webcast replay available one hour after the conclusion of Dr. Ashton's presentation that day and it will be available until May 11, 2014.

Research and Markets: Commercial Construction in New Zealand to 2017: Market Forecast Report
Business Wire - Thu Feb 06, 4:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/gfx4k6/commercial) has announced the addition of the "Commercial Construction in New Zealand to 2017: Market Forecast" report to their offering.

pSivida Corp Announces Second Quarter 2014 Financial Results Release Date and Conference Call Information
Business Wire - Thu Jan 30, 3:39PM CST
pSivida Corp. (NASDAQ SDV) (ASX VA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its financial results for the second quarter of fiscal year 2014 will be released after the market close on Friday, February 7, 2014, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.

3 Stocks Under $10 Moving Higher
at The Street - Wed Jan 29, 6:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 122

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 64

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 122

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 127

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 113

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 82

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 97

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
Charlotte's Top-Tier Home Sales Surge: A $15M Milestone

Updated Category News Views 114

Charlotte's Luxury Market: A Rapid Ascent Folks, buckle up, because the luxury home market in Charlotte isn't just on the rise—it's practically sky-high. Back in 2016, the idea of splashing out over $5 million on a house was almost unheard of in this neck of the woods. Only one brave soul did it at the time. Fast forward to this past year, and things are looking starkly...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 116

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading

Top 5 Most Recently Viewed Articles

Passage Bio's Upcoming Presentation at Genetic Medicines Conference

Updated Category News Views 45

Passage Bio's Work in Genetic Medicine Advancements Passage Bio, Inc. (NASDAQ: PASG), based in Philadelphia, is making notable progress in the area of genetic therapies, with a mission to offer hope to patients battling neurodegenerative diseases. Will Chou, M.D., the company's president and CEO, is set to present at the esteemed Chardan's 8th Annual Genetic Medicines...

Continue Reading
Experience the Sweet Taste of Christmas with Purdys Chocolatier

Updated Category News Views 248

Discover the Magic of the Holiday Season with Purdys Purdys Chocolatier, a beloved Canadian chocolatier since 1907, is getting ready to sprinkle some festive cheer this holiday season. With a delightful range of holiday chocolates, they aim to make every home a little sweeter. Purdys Chocolatier’s Christmas Collection is sure to have something special for everyone on...

Continue Reading
Warmy.io Launches Adeline AI to Enhance Email Deliverability

Updated Category News Views 253

Enhancing Email Deliverability with Adeline AI Warmy.io, a cutting-edge platform focused on improving email deliverability, has made waves in the digital marketing realm with its innovative solution, Adeline AI. This advanced system is designed to tackle one of the most pressing challenges in email marketing—ensuring that emails reach the primary inbox instead of...

Continue Reading
Unleashing the Potential of Community-Based Trials for Health

Updated Category News Views 87

Understanding Community-Based Trials In a unique approach to enhancing clinical research, community-based trials are making significant strides by prioritizing patient accessibility. This webinar is designed to provide an enlightening perspective on how these trials are tailored to meet the needs of local populations. The focus will be on how community-site networks and...

Continue Reading
Dovid Oved Retreat Center's Generous Support for Firefighters

Updated Category News Views 203

A Community's Commitment to Emergency Responders The Dovid Oved Retreat Center recently hosted a heartfelt barbecue to show appreciation for over 110 firefighters battling the devastating Line Fire. This wildfire has consumed large areas of land and posed a significant threat not only to the retreat center but also to the local community. Offering Essential Resources...

Continue Reading